ArticleHarm reduction journal2017
Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver.
Article in Harm reduction journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019Guideline
- Crack-cocaine use practices, harms and respiratory problems: an analysis of gender differences using data from a cross-sectional survey in England.BMC public health · 2026Article
- A qualitative study of the impacts of a government crackdown against revenue sharing between pharmacies and patients in Vancouver, Canada.Discover public health · 2026Article
- Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada.Harm reduction journal · 2025Article
- "The people who depended on us became expendable": Experiences of frontline workers with lived and living expertise of drug use during the COVID-19 pandemic.Harm reduction journal · 2025Article
- "It's a delicate balance": clinicians' experiences of providing heroin-assisted treatment.Harm reduction journal · 2024Article
- Safe inhalation pipe provision (SIPP): protocol for a mixed-method evaluation of an intervention to improve health outcomes and service engagement among people who use crack cocaine in England.Harm reduction journal · 2024Article
- Vancouver's Alcohol Knowledge Exchange: lessons learned from creating a peer-involved alcohol harm reduction strategy in Vancouver's Downtown Eastside.Harm reduction journal · 2023Review
- Patients' satisfaction with heroin-assisted treatment: a qualitative study.Harm reduction journal · 2023Article
- 'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England.Harm reduction journal · 2023Article
- "I am not a junkie": Social categorization and differentiation among people who use drugs.The International journal on drug policy · 2023Article
- Article
- The overdose epidemic: a study protocol to determine whether people who use drugs can influence or shape public opinion via mass media.Health & justice · 2022Article
- Case report: acute care management of severe opioid withdrawal with IV fentanyl.Addiction science & clinical practice · 2022Article
- Shifting North American drug markets and challenges for the system of care.International journal of mental health systems · 2021Article
- Peer Support and Overdose Prevention Responses: A Systematic 'State-of-the-Art' Review.International journal of environmental research and public health · 2021Review
- What are the ethical implications of using prize-based contingency management in substance use? A scoping review.Harm reduction journal · 2021Article
- Comparing Canadian and United States opioid agonist therapy policies.The International journal on drug policy · 2019Article
- An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada.Substance abuse treatment, prevention, and policy · 2018Article
- Review
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis article highlights the experiences of a peer-run group, SALOME/NAOMI Association of Patients (SNAP), that meets weekly in the Downtown Eastside of Vancouver, British Columbia, Canada. SNAP is a unique independent peer- run drug user group that formed in 2011 following Canada's first heroin-assisted treatment trial (HAT), North America Opiate Medication Initiative (NAOMI). SNAP's members are now made up of former research participants who participated in two heroin-assisted trials in Vancouver. This article highlights SNAP members' experiences as research subjects in Canada's second clinical trial conducted in Vancouver, Study to Assess Longer-term Opioid Medication Effectiveness (SALOME), that began recruitment of research participants in 2011.
methodsThis paper draws on one brainstorming session, three focus groups, and field notes, with the SALOME/NAOMI Association of Patients (SNAP) in late 2013 about their experiences as research subjects in Canada's second clinical trial, SALOME in the DTES of Vancouver, and fieldwork from a 6-year period (March 2011 to February 2017) with SNAP members. SNAP's research draws on research principles developed by drug user groups and critical methodological frameworks on community-based research for social justice.
resultsThe results illuminate how participating in the SALOME clinical trial impacted the lives of SNAP members. In addition, the findings reveal how SNAP member's advocacy for HAT impacts the group in positive ways. Seven major themes emerged from the analysis of the brainstorming and focus groups: life prior to SALOME, the clinic setting and routine, stability, 6-month transition, support, exiting the trial and ethics, and collective action, including their participation in a constitutional challenge in the Supreme Court of BC to continue receiving HAT once the SALOME trial ended.
conclusionsHAT benefits SNAP members. They argue that permanent HAT programs should be established in Canada because they are an effective harm reduction initiative, one that also reduces opioid overdose deaths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.